期刊文献+

尼卡地平联合卡维地洛治疗肾性高血压21例 被引量:2

Nicardipine Combined with Carvedilol in the Treatment of 21 Cases of Renal Hypertension
下载PDF
导出
摘要 目的观察尼卡地平联合卡维地洛治疗肾性高血压的疗效和安全性。方法将49例肾性高血压患者随机分为两组。对照组28例,给予尼卡地平80mg,q8h;治疗组21例,在对照组基础上加卡维地洛25—50mg,qd。两组均连用8周。监测治疗前后血压、心率、肾功能等。结果对照组降血压总有效率为67.86%,治疗组总有效率为80.95%。两组患者治疗前后心率、肾功能等均无明显改变,无明显不良反应。结论尼卡地平联合卡维地洛治疗肾性高血压安全有效,其疗效优于单用尼卡地平。 Objective To observe the therapeutic effect and safety of nicardipine combined with carvedilol on renal hypertension. Methods Forty-nine renal hypertension patients were randomly divided into two groups. Patients in the control group were treated with nicardipine 80 mg q 8 h, while patients in treatment group nicardipine 40 mg q 8 h and carvedilol 25 - 50 mg qd for 8 weeks. Blood pressure, heart rate, renal function were detected before and after treatment. Results Total efficiency of lowering blood pressure in the control group was 67, 86% , and that in the treatment group was 80, 95%, There were no significant changes in heart rate, and renal function before and after treatment in two groups with no obvious adverse events. Conclusion Nicardipine combined with carvedilol was efficient and safe for the treatment of renal hypertension, which was more efficient than nicardipine alone.
出处 《医药导报》 CAS 2008年第1期43-45,共3页 Herald of Medicine
关键词 尼卡地平 卡维地洛 高血压 肾性 Nicardipine Carvedilol Hypertension, renal
  • 相关文献

参考文献9

二级参考文献36

  • 1程颖,田文,张子新,张月兰,胡健.静脉滴注尼卡地平对心力衰竭患者康复的影响[J].现代康复,1999,3(11):1394-1394. 被引量:2
  • 2黄震华.新型钙通道拮抗剂尼卡地平[J].国外医药(合成药.生化药.制剂分册),1995,16(2):91-93. 被引量:10
  • 3Suzuki S, Ohtsuka S, Ishikawa K, et al. Effects of nicardipine on coronary vertebral and renal arterial flows in patients with essential hypertension. Hypertens Res,2003, 26:193--199.
  • 4Sorkin E M, Clissold S P. A review of nicardipine oharma-cokinetic and properties,and therapeutic efficacy, in the treatment of angina pectoris, hypertension and relted cardiovascular disorders. Drugs, 1987, 33:296 --297.
  • 5中国高血压防治指南修订委员会.中国高血压防治指南(2005年修订版)[M].北京:人民卫生出版社,2005.
  • 6CHOBANIAN A V,BAKRIS G L,BLACK H R,et al.The seventh report of the joint national committee on prevention,detection,evaluation and treatment of high blood pressure:the JNC-7 report[J].JAMA,2003,289(22):2560-2572.
  • 7Guidelines Committee.2003 European Society of Hypertension European Society of Cardiology guidelines for the management of arterial hypertension[J].J Hypertens,2003,21:1021-1053.
  • 8ANON.Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)[J].JAMA,2002,288(23):2981 -2997.
  • 9JOUNELA A J,LILJA M,LUMMEJ,et al.Relation between low dose of hydrochlorothiazide,antihypertensive effect and adverse effects[J].Blood Press,1994,3:231-235.
  • 10POOLE-WILSON PA,LABSEN J,KIRWAN B A,et al.Effect of long acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial):randomized controlled trial[J].Lancet,2004,364 (9437):849 -857.

共引文献95

同被引文献15

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部